Management of irritable bowel syndrome in primary care: feasibility randomised controlled trial of mebeverine, methylcellulose, placebo and a patient self-management cognitive behavioural therapy website (MIBS trial) [PDF]
Background: IBS affects 10-22% of the UK population. Abdominal pain, bloating and altered bowel habit affectquality of life, social functioning and time off work.
Tapp Laura +24 more
core +2 more sources
Alosetron: An Effective Treatment for Diarrhea-Predominant Irritable Bowel Syndrome
Serotonin (5-HT) is one of the key mediators of gut motility, secretion and sensation. Most 5-HT is localized in the gastrointestinal tract. Particularly important for gut function and regulation are the 5-HT1P, 5-HT3and 5-HT4receptors. These receptors have been the focus of research evaluating the pathophysiologic mechanisms of irritable bowel ...
Lucinda A, Harris, Lin, Chang
openaire +2 more sources
Raised Amylase as a Potential Marker of Vascular Dysfunction and Inflammation in Fabry Disease
ABSTRACT Fabry disease (FD) is a X‐linked disorder caused by deficiency of alpha‐galactosidase A (AGAL), leading to progressive accumulation of globotriaosylceramide (Gb3) and globotriaosylsphingosine (lyso‐Gb3). While renal, cardiac and cerebrovascular complications are well described, pancreatic involvement remains poorly characterised.
Simona D'Amore +2 more
wiley +1 more source
BACKGROUND: Irritable bowel syndrome (IBS) is the most common functional bowel disorder and has a strong predominance in women. Recent data suggest that the brain may play an important role in the pathophysiology of IBS in the brain-gut axis.
Akio Nakai +6 more
doaj +1 more source
Sequelae of Traveler's Diarrhea: Focus on Postinfectious Irritable Bowel Syndrome [PDF]
Traveler's diarrhea is usually an acute, self-limited illness; however, in some patients, enteric symptoms can persist for weeks, months, or years. It has been estimated that up to 3% of patients with traveler's diarrhea have symptoms for >30 days. The differential diagnosis includes persistent infection, coinfection, temporary postinfection phenomena,
openaire +2 more sources
Complementary and alternative medicine use by patients in pediatric gastroenterology clinics
Abstract Objectives Use of complementary and alternative medicine (CAM) therapies among children seen in pediatric gastroenterology (GI) clinics is high. Multiple CAM therapies are effective as primary and adjuvant therapies for GI disorders and symptoms. Our study aimed to define the historical use of CAM and interest in CAM therapies in a specialized
Joshua D. Prozialeck +3 more
wiley +1 more source
Eluxadoline in the Treatment of Irritable Bowel Syndrome with Diarrhea
Irritable bowel syndrome (IBS) is a functional bowel disorder characterized by chronic abdominal pain and constipation (IBS-C), diarrhea (IBS-D), or a mixed pattern of altered bowel habits (IBS-M). It has a prevalence of 12% in North America with approximately one-third of patients having IBS-D in the United States.
openaire +1 more source
ChREBP deficiency leads to diarrhea-predominant irritable bowel syndrome
Fructose malabsorption is a common digestive disorder in which absorption of fructose in the small intestine is impaired. An abnormality of the main intestinal fructose transporter proteins has been proposed as a cause for fructose malabsorption. However the underlying molecular mechanism for this remains unclear. In this study, we investigated whether
Ah-Reum, Oh +8 more
openaire +4 more sources
ABSTRACT Background Irritable bowel syndrome (IBS) is a disorder of gut‐brain interaction often accompanied by psychiatric and/or somatic comorbidities. Intestinal‐barrier dysfunction has been implicated in IBS pathophysiology. However, the contribution of psychiatric and somatic comorbidities to intestinal permeability remains unclear.
Alice Rustichelli +33 more
wiley +1 more source

